Capstone Asset Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
PAI
EWM
BCM
Capstone Asset Management's ABMD Position: Q2 2017 in Review
Capstone Asset Management increased its Abiomed Inc (ABMD) stake by 1.1% in Q2 2017, buying an estimated $9.41K and bringing the position to 6,410 shares worth $919K. The position accounts for 0.03% of the portfolio, ranked #618.
Capstone Asset Management first reported a position in ABMD in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.57M in Q1 2015. 303 funds tracked by Wall St. Rank hold ABMD as of Q2 2017.
- Capstone Asset Management held 6,410 shares of Abiomed Inc worth $919K as of Q2 2017.
- Capstone Asset Management bought 70 Abiomed Inc shares in Q2 2017, an estimated $9.41K.
- Abiomed Inc made up 0.03% of Capstone Asset Management's portfolio in Q2 2017, its #618 holding.
- Capstone Asset Management first reported a position in Abiomed Inc in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Abiomed Inc position peaked at $1.57M in Q1 2015.
- 303 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.